Charles L Knupp
Research Subjects
Research Interests
Charles L Knupp has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Abdullah Kutlar
Medical College of Georgia, Augusta, GA, USA
1 shared publication - Andrew Lawrence Frelinger
Harvard Medical School, Boston, MA, USA; Dana Farber/Boston Children's Cancer and Blood Disorders Center, Boston Children's Hospital, Boston, MA, USA
1 shared publication - Chuke E Nwachuku
12Daiichi Sankyo, Inc, Edison, NJ, USA
1 shared publication - Chunmei Zhou
Eli Lilly and Company, Indianapolis, IN 46285, USA
1 shared publication - Denis Soulières
1560, rue Sherbrooke estx, Department of Hematology and Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, QC H2L 4MN, Canada
1 shared publication - Enrico M. Novelli
Division of Classical Hematology, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA
1 shared publication
Latest Publications
- Open Access
- 17 February 2013
- Published by Springer Nature in Journal of Hematology & Oncology
- Vol. 6 (1) , 17
A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease
Platelet activation has been implicated in the pathogenesis of sickle cell disease (SCD) suggesting antiplatelet agents may be therapeutic. To evaluate the safety of prasugrel, a thienopyridine antiplatelet agent, in adult patients with SCD, we conducted a double-blind, randomized, placebo-controlled study.
- 17 February 2013
- Published by Springer Nature in Journal of Hematology & Oncology
- Vol. 6 (1) , 17
Open AccessA double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease
Platelet activation has been implicated in the pathogenesis of sickle cell disease (SCD) suggesting antiplatelet agents may be therapeutic. To evaluate the safety of prasugrel, a thienopyridine antiplatelet agent, in adult patients with SCD, we conducted a double-blind, randomized, placebo-controlled study.